CanSino Biologics Inc Net Asset Momentum
CanSino Biologics Inc net asset momentum. CanSino Biologics Inc (CJH) recorded a net asset momentum of 0.9% as of December 2025, with net assets of €4.95 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore CJH capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of CanSino Biologics Inc (2016–2025)
Net asset momentum of CanSino Biologics Inc from 2016 to 2025. This chart tracks CanSino Biologics Inc's year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is +0.9%, with net assets of €4.95 Billion EUR as of December 2025. See CanSino Biologics Inc shareholders equity for net asset value and shareholders' equity analysis.
CanSino Biologics Inc Net Asset Momentum by Year (2016–2025)
CanSino Biologics Inc net asset momentum by year from 2016 to 2025. The table below shows the complete annual net asset history for CanSino Biologics Inc from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see how much is CanSino Biologics Inc worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €4.95 Billion | €7.18 Billion | €2.22 Billion | ▲ +0.9% |
| 2024 | €4.91 Billion | €7.96 Billion | €3.05 Billion | ▼ -7.1% |
| 2023 | €5.29 Billion | €9.32 Billion | €4.03 Billion | ▼ -27.0% |
| 2022 | €7.25 Billion | €11.47 Billion | €4.22 Billion | ▼ -15.2% |
| 2021 | €8.55 Billion | €11.87 Billion | €3.33 Billion | ▲ +40.8% |
| 2020 | €6.07 Billion | €6.75 Billion | €677.22 Million | ▲ +312.8% |
| 2019 | €1.47 Billion | €1.78 Billion | €313.98 Million | ▲ +192.7% |
| 2018 | €502.32 Million | €795.88 Million | €293.56 Million | ▼ -17.3% |
| 2017 | €607.33 Million | €866.36 Million | €259.03 Million | ▲ +183.2% |
| 2016 | €214.47 Million | €326.17 Million | €111.70 Million | — |